MGRXMANGOCEUTICALS, INC.

Nasdaq www.mangorx.com


$ 0.45 $ 0.03 (7 %)    

Tuesday, 28-May-2024 15:22:14 EDT
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 0.44
$ 0.41
$ 0.00 x 0
$ 0.00 x 0
$ 0.37 - $ 0.45
$ 0.14 - $ 2.38
1,778,380
na
10.92M
$ -3.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mangoceuticals-develops-oral-glp-1s-stock-soars

Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("...

 mangoceuticals-q1-eps-010-up-from-023-yoy-sales-21409k-up-from-10072k-yoy

Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.10) per share. This is a 56.52 percent increase over losses of $(...

 mangorx-acquires-patent-portfolio-for-total-of-20m-through-issuance-of-980k-of-6-series-c-convertible-preferred-shares

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, a...

 mangoceuticals-subsidiary-mangorx-mexico-executes-technical-agreement-with-mexican-pharmaceutical-manufacturer-for-initial-development-and-production-of-its-mango-erectile-dysfunction-products

Signifies the first major step towards the application process for the certification of itsMango ED oral dissolvable products b...

 why-salarius-pharmaceuticals-shares-are-trading-higher-by-around-31-here-are-20-stocks-moving-premarket

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter re...

 why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

 mangorx-launches-prime-by-mangorx-powered-by-kyzatrex-fda-approved-oral-testosterone-replacement-therapy-treatment

The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatme...

 mangorx-launches-direct-to-clinics-sales-division

Newly developed clinic prescribing system will allow Doctors to prescribe MangoRx products from within practices and clinics

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION